[HTML][HTML] Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao, A Chen… - Journal of Translational …, 2015 - Springer
Background Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …

Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao, A Chen… - Journal of Translational …, 2015 - infona.pl
Background Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …

Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang… - Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …

[PDF][PDF] Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao, A Chen… - 2015 - researchgate.net
Background: Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …

[引用][C] Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao… - Journal of Translational …, 2015 - cir.nii.ac.jp

[HTML][HTML] Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang… - Journal of …, 2015 - … -medicine.biomedcentral.com
Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical source of reactive
oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) injury. Inhibition of XO is …

Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao… - Journal of …, 2015 - go.gale.com
Background Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …

[HTML][HTML] Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao… - Journal of …, 2015 - ncbi.nlm.nih.gov
Background Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …

Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao… - Journal of …, 2015 - search.proquest.com
Background Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …

[PDF][PDF] Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis

S Wang, Y Li, X Song, X Wang, C Zhao, A Chen… - 2015 - cyberleninka.org
Background: Febuxostat is a selective inhibitor of xanthine oxidase (XO). XO is a critical
source of reactive oxygen species (ROS) during myocardial ischemia/reperfusion (I/R) …